COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: a case-control study.

Area of Science:

• Neurogenetics
• Psychiatric Disorders
• Molecular Genetics

Background:

• Schizophrenia and obsessive-compulsive disorder (OCD) are complex psychiatric conditions.
• The catechol-O-methyltransferase (COMT) gene, specifically the Val158Met polymorphism, has been implicated in various neurological and psychiatric disorders.
• A potential molecular genetic link between schizophrenia and OCD warrants investigation.

Purpose of the Study:

• To examine the association between the COMT Val158Met polymorphism and the co-occurrence of schizophrenia and OCD.
• To compare the distribution of COMT Val158Met genotypes in patients with schizophrenia-OCD, patients with OCD, and healthy controls.

Main Methods:

• A case-control association study design was employed.
• Genotyping for the COMT Val158Met polymorphism was performed on 113 schizophrenia-OCD patients, 79 OCD patients, and 171 healthy controls.
• Allele and genotype frequencies were analyzed between the groups.

Main Results:

• No significant differences in COMT Val158Met allele or genotype distributions were found between schizophrenia-OCD patients and healthy controls.
• The low-activity Met allele and Met/Met genotype were observed more frequently in OCD men compared to other groups, but this finding was not statistically significant after multiple comparisons correction.
• These results do not support a direct association between the COMT Val158Met polymorphism and schizophrenia-OCD.

Conclusions:

• The COMT Val158Met gene polymorphism is unlikely to be a major genetic risk factor for schizophrenia-OCD.
• Further research may explore other genetic variants or environmental factors contributing to the comorbidity of schizophrenia and OCD.
• Investigating the role of COMT in OCD specifically, particularly in males, warrants further study with larger sample sizes.